Biopharmaceuticals
Active 2016–2026. The register lists this client once for every firm that files on its behalf; all 5 of its records are shown together here.
These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2026 | ALSTON & BIRD LLP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$80,000 | |
| 2026 | TRAVERE THERAPEUTICS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$100,000 | |
| 2026 | THE HEALTH EQUITY STRATEGIES GROUP, LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$16,000 | |
| 2026 | ALSTON & BIRD LLP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$70,000 | |
| 2026 | TRAVERE THERAPEUTICS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$140,000 | |
| 2026 | THE HEALTH EQUITY STRATEGIES GROUP, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$16,000 | |
| 2026 | ALSTON & BIRD LLP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$80,000 | |
| 2026 | TRAVERE THERAPEUTICS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$200,000 | |
| 2025 | ALSTON & BIRD LLP |
1st Quarter (Jan 1 - Mar 31) AMENDED |
$60,000 | |
| 2025 | THE HEALTH EQUITY STRATEGIES GROUP, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$16,000 |
| Firm | Filings | Amount |
|---|---|---|
| TRAVERE THERAPEUTICS IN-HOUSE | 45 | $6,655,000 |
| ALSTON & BIRD LLP | 42 | $2,430,000 |
| THE HEALTH EQUITY STRATEGIES GROUP, LLC | 22 | $393,000 |
| 2359 STRATEGIES | 18 | $305,000 |
| CROSSROADS STRATEGIES, LLC | 9 | $150,000 |
| Issue | Activities |
|---|---|
| Health Issues | 135 |
| Pharmacy | 125 |
| Medicare/Medicaid | 121 |
| Medical/Disease Research/Clinical Labs | 119 |
| Taxation/Internal Revenue Code | 86 |
| Copyright/Patent/Trademark | 48 |
| Budget/Appropriations | 2 |
| Trade (domestic/foreign) | 1 |
| Government Issues | 1 |
| Education | 1 |